Lanean...

Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database

This report examines relapse risk following a switch from risperidone long-acting injectable (RLAI) to another long-acting injectable antipsychotic [paliperidone palmitate (PP)] versus a switch to oral antipsychotics (APs). Truven Health’s MarketScan Multistate Medicaid Database compared relapses fo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int Clin Psychopharmacol
Egile Nagusiak: Voss, Erica A., Ryan, Patrick B., Stang, Paul E., Hough, David, Alphs, Larry
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams And Wilkins 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383368/
https://ncbi.nlm.nih.gov/pubmed/25730525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000068
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!